Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2016
Yan Kang is an author specializing in cancer pharmacology, tumor-associated antigen targeting, and antibody-drug conjugate antibodies.
Publications per year
2016–2016
First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848)
A. Gazzah, Neda Stjepanovic, Min‐Hee Ryu et al. · European Journal of Cancer · 2016 · 10 citations
Pharmacy, Oncology, Pharmacology +13
1–1 of 1